These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25528188)

  • 21. Validation of a next-generation sequencing assay for clinical molecular oncology.
    Cottrell CE; Al-Kateb H; Bredemeyer AJ; Duncavage EJ; Spencer DH; Abel HJ; Lockwood CM; Hagemann IS; O'Guin SM; Burcea LC; Sawyer CS; Oschwald DM; Stratman JL; Sher DA; Johnson MR; Brown JT; Cliften PF; George B; McIntosh LD; Shrivastava S; Nguyen TT; Payton JE; Watson MA; Crosby SD; Head RD; Mitra RD; Nagarajan R; Kulkarni S; Seibert K; Virgin HW; Milbrandt J; Pfeifer JD
    J Mol Diagn; 2014 Jan; 16(1):89-105. PubMed ID: 24211365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted multiplex next-generation sequencing: advances in techniques of mitochondrial and nuclear DNA sequencing for population genomics.
    Hancock-Hanser BL; Frey A; Leslie MS; Dutton PH; Archer FI; Morin PA
    Mol Ecol Resour; 2013 Mar; 13(2):254-68. PubMed ID: 23351075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data.
    Grasso C; Butler T; Rhodes K; Quist M; Neff TL; Moore S; Tomlins SA; Reinig E; Beadling C; Andersen M; Corless CL
    J Mol Diagn; 2015 Jan; 17(1):53-63. PubMed ID: 25468433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Random Tagging Genotyping by Sequencing (rtGBS), an Unbiased Approach to Locate Restriction Enzyme Sites across the Target Genome.
    Hilario E; Barron L; Deng CH; Datson PM; De Silva N; Davy MW; Storey RD
    PLoS One; 2015; 10(12):e0143193. PubMed ID: 26633193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple method for semi-random DNA amplicon fragmentation using the methylation-dependent restriction enzyme MspJI.
    Shinozuka H; Cogan NO; Shinozuka M; Marshall A; Kay P; Lin YH; Spangenberg GC; Forster JW
    BMC Biotechnol; 2015 Apr; 15():25. PubMed ID: 25887558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of genomic copy number alteration emphasizing a restriction site-based strategy of genome re-sequencing.
    Zheng C; Miao X; Li Y; Huang Y; Ruan J; Ma X; Wang L; Wu CI; Cai J
    Bioinformatics; 2013 Nov; 29(22):2813-21. PubMed ID: 23962614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-generation sequencing for the general cancer patient.
    Avila M; Meric-Bernstam F
    Clin Adv Hematol Oncol; 2019 Aug; 17(8):447-454. PubMed ID: 31449513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective DNA fragmentation technique for simple sequence repeat detection with a microsatellite-enriched library and high-throughput sequencing.
    Tanaka K; Ohtake R; Yoshida S; Shinohara T
    Biotechniques; 2017 Apr; 62(4):180-182. PubMed ID: 28403809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes.
    Jacoby MA; Walter MJ
    Expert Rev Mol Diagn; 2012 Apr; 12(3):253-64. PubMed ID: 22468816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live births after simultaneous avoidance of monogenic diseases and chromosome abnormality by next-generation sequencing with linkage analyses.
    Yan L; Huang L; Xu L; Huang J; Ma F; Zhu X; Tang Y; Liu M; Lian Y; Liu P; Li R; Lu S; Tang F; Qiao J; Xie XS
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15964-9. PubMed ID: 26712022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.
    Chen MJ; Wei SY; Yang WS; Wu TT; Li HY; Ho HN; Yang YS; Chen PL
    Hum Reprod; 2015 Jul; 30(7):1732-42. PubMed ID: 25924657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of methods for identifying somatic copy number alterations from deep sequencing data.
    Alkodsi A; Louhimo R; Hautaniemi S
    Brief Bioinform; 2015 Mar; 16(2):242-54. PubMed ID: 24599115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards a Next-Generation Sequencing Diagnostic Service for Tumour Genotyping: A Comparison of Panels and Platforms.
    Burghel GJ; Hurst CD; Watson CM; Chambers PA; Dickinson H; Roberts P; Knowles MA
    Biomed Res Int; 2015; 2015():478017. PubMed ID: 26351634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next-generation sequencing of custom amplicons to improve coverage of HaloPlex multigene panels.
    Coonrod EM; Durtschi JD; VanSant Webb C; Voelkerding KV; Kumánovics A
    Biotechniques; 2014 Oct; 57(4):204-7. PubMed ID: 25312090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The next generation of target capture technologies - large DNA fragment enrichment and sequencing determines regional genomic variation of high complexity.
    Dapprich J; Ferriola D; Mackiewicz K; Clark PM; Rappaport E; D'Arcy M; Sasson A; Gai X; Schug J; Kaestner KH; Monos D
    BMC Genomics; 2016 Jul; 17():486. PubMed ID: 27393338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics: Role of Single Nucleotide Polymorphisms.
    Yucesan E; Ozten N
    Methods Mol Biol; 2019; 2054():137-145. PubMed ID: 31482453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting.
    Hinchcliffe M; Le H; Fimmel A; Molloy L; Freeman L; Sullivan D; Trent RJ
    Pathology; 2014 Jan; 46(1):60-8. PubMed ID: 24300713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole Genome Library Construction for Next Generation Sequencing.
    Keats JJ; Cuyugan L; Adkins J; Liang WS
    Methods Mol Biol; 2018; 1706():151-161. PubMed ID: 29423797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA hypomethylation in plasma as a cancer biomarker: when less is more?
    Henrique R; Jerónimo C
    Expert Rev Mol Diagn; 2014 May; 14(4):419-22. PubMed ID: 24689646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.